Long-term immunotherapy with low-dose interleukin-2 and interferon-? in the treatment of patients with advanced renal cell carcinoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference45 articles.
1. A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
2. Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignancies
3. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
4. Low-Dose lnterleukin-2 in Combination with Interferon-α Effectively Modulates Biological Response in vivo
5. A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy;Immunology;2024-04-15
2. The Effects of Chinese Herbal Decoction Combined with Recombinant Human Interferon α2b on MRI Imaging, Tumor Markers, and Immune Function in Patients with Renal Cell Carcinoma;Evidence-Based Complementary and Alternative Medicine;2021-10-25
3. Resveratrol Activates Natural Killer Cells through Akt- and mTORC2-Mediated c-Myb Upregulation;International Journal of Molecular Sciences;2020-12-16
4. In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation;Journal of Innate Immunity;2020-09-16
5. The Deleterious Impact of Interleukin 9 to Hepatorenal Physiology;Inflammation;2019-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3